Jennifer L. Dotson

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Role not yet determined Is this you? Add your title

UAMS

Also affiliated: University of Notre Dame (2014); University of North Carolina at Chapel Hill (2015–2017); Lurie Children's Hospital (2016); Albert Einstein College of Medicine (2017); Arkansas Children's Hospital (2025–2026); American Academy of Pediatrics (2022); Pennsylvania State University (2016); Nationwide Children's Hospital (2007–2025); Morristown Medical Center (2010); The Ohio State University Wexner Medical Center (2021–2025); Goryeb Children's Hospital (2016); The Ohio State University (2007–2025); Penn State Milton S. Hershey Medical Center (2016)

18 h-index 136 pubs 1,258 cited

Research Areas

Biomedical Subjects

Links

ORCID

OverviewAI-generated summary

Jennifer L. Dotson's research has primarily focused on pediatric inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis. Her work has investigated disease mechanisms, such as the role of gene expression in stricturing behavior in pediatric Crohn's disease. Dotson has also examined extraintestinal manifestations of IBD in children and the impact of treatments like tumor necrosis factor-α blockers, including a retrospective analysis of histoplasmosis complications in patients receiving these therapies. Her publications address racial disparities in readmission, complications, and procedures for children with Crohn's disease, as well as the feasibility of activity indices in clinical practice for ulcerative colitis. Dotson's scholarship metrics include an h-index of 18, 159 total publications, and 1,319 total citations.

Metrics

h-index: 18
Publications: 136
Citations: 1,258

Selected Publications

Treatment patterns among pediatric and adult patients with ulcerative colitis in the United States: a retrospective cohort study (2026)

Current Medical Research and Opinion DOI OpenAlex
Multicenter experience using tofacitinib for treatment of refractory pediatric inflammatory bowel diseases in the United States (2026)

Journal of Pediatric Gastroenterology and Nutrition 1 citation DOI OpenAlex
Frequency and impact of repeat colonoscopy as a treat‐to‐target approach in pediatric inflammatory bowel disease (2025)

JPGN Reports DOI OpenAlex
The Transition Care Index: Standardizing comprehensive transition and transfer for young adults with inflammatory bowel disease (2025)

JPGN Reports DOI OpenAlex
National perspectives of barriers by insurance and pharmacy benefit managers in pediatric inflammatory bowel disease (2025)

JPGN Reports 2 citations DOI OpenAlex
Pediatric Gastrointestinal Tract Outcomes During the Postacute Phase of COVID-19 (2025)

JAMA Network Open 11 citations DOI OpenAlex
P0421 Clinical validity of a seroproteomic index of endoscopic activity in pediatric Crohn’s disease (2025)

Journal of Crohn s and Colitis DOI OpenAlex